Triathlon Medical Ventures Triathlon Medical Ventures
Triathlon Medical Ventures Triathlon Medical Ventures Triathlon Medical Ventures
Triathlon Medical Ventures - Homepage
Triathlon Medical Ventures - Team
Triathlon Medical Ventures - Investment Focus
Triathlon Medical Ventures - Investment Strategy
Triathlon Medical Ventures - Investment Criteria
Contact Triathlon Medical Ventures - Evaluation Process
Triathlon Medical Ventures - Portfolio
Triathlon Medical Ventures - News
Triathlon Medical Ventures - Links
Contact Contact Triathlon Medical Ventures

Triathlon Medical Ventures

 

 

 

 


 

NEWS ARCHIVES (VIEW CURRENT NEWS)

October 31, 2008
Mitralign® Initiates it's First European Study


October 31, 2008
Symphony Drums Up $10M On Way To Series C


October 28, 2008
CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development


October 10, 2008
AcelleRX Therapeutics Raises $6.9 Million From Investors


September 3, 2008
Triathlon Medical Ventures Adds New Company to Portfolio — Expanding Orthopedics, Inc. Offers Broad Platform of Cutting-edge Technology


July 11, 2008
CoLucid Tries to Prove That a Virtual Biotech Can Produce Real Returns

July 1, 2008
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound

June 6, 2008
Tolera Therapeutics Closes Series A Financing, Raises $8 Million to Begin Antibody Manufacturing and Working With FDA on Clinical Trials


April 22, 2008
FDA Agrees to First SPA for an Oncolytic Product


February 15, 2008
Symphony Medical thinks it can tackle large cardiology markets with its seemingly simple approach to alter troubled hearts

February 8, 2008
Triathlon Invests In Cancer Firm

November 29, 2007
Renal Solutions, Inc. Announces Acquisition by Fresenius Medical Care

September 21, 2007
Pradama Pharmaceutial Firms Gets Second-Round Funding


September 20, 2007
BioVex Appoints Dr. Leonard Post to Board of Directors

August 27, 2007
P&G Job Got Foot in the Door


July 17, 2007
The Picture of Success: HydroCision Inc.


July 9, 2007
BioVex Raises $22 Million in First Close of Series E Financing

June 25, 2007
Boston Scientific Announces Agreement to Acquires Remon Medical Technlogies, Inc.


March 23 , 2007
Endocyte Secures $15 Million in Series C-3 Round of Financing


February 13, 2007
CS-Keys in Forefront of Fight Against Cancer

January 2 , 2007
BioCrossroads CEO: Help Life Sciences Grow

December 21, 2006
Firm Develops High-Tech Medical Tool... Device Useful for Back Surgery

December 19, 2006
VC Brings Investment Muscle to Hoosier Life-Sciences Startups

December 11, 2006
HydroCision Announces $12.7 Million Venture Financing ... Dennis B. Costello, Managing Partner, Triathlon Medical Ventures, Joins HydroCision's Board of Directors

November 7, 2006
Mitralign Shines at TCT 2006; Performs Live Case & Reveals Clinical Strategy

October 9, 2006
Michael A. Sherman Joins Endocyte as CFO


October 6, 2006
Remon Medical Announces First European Implants of the Remon ImPressureTM, A Wireless Device for Monitoring Pulmonary Artery Pressure in Congestive Heart Failure Patients


July 18, 2006
Renal Solutions Announces Medical Advisory Board

July 17, 2006
A Company Formed by Indiana University Researchers has Received a Significant Seed Investment from Triathlon Medical Ventures


June 27, 2006
Renal Solutions Announces Addition to Board of Directors


June 8, 2006
Renal Solutions Announces FDA 501(k) Clearance of the Allient Sorbent Hemodialysis System for Chronic and Acute Hemodialysis


May 2, 2006
Cincinnati VC Firm Triathlon Adds $9M to Fund, Closes at $105M

April 27, 2006
Ohio PERS Keeps Money at Home - Retirement System Invests $27 Million in Local Firms

April 20, 2006
Endocyte Begins Phase 1 Trial of EC145 for Treatment of Refractory Solid Tumors

April 20, 2006
Mitralign Announces New Investment by Triathlon Medical Ventures


February 28, 2006
Cleveland Clinic Spin-Off Raises $6 Million to Develop Treatments for Atrial Fibrillation

January 17, 2006
CoLucid Pharmaceuticals Announces $16.5 Million Series A Financing

January 5, 2006
Endocyte Signs Agreement with Bristol-Myers Squibb to Develop and Commercialize Folate-Targeted Chemotherapeutic Agents

November 15, 2005
Kereos' Collaborators Present on Targeted Therapies for Cardiovascular Disease

November 1, 2005
Celleratio
n® Receives $20.6 Million in Series C Funding

July 11, 2005
$10 Million Seed Fund About to Take Off - Venture Fund Will Invest in Early - Stage Life Sciences Companies Across the State


June 22, 2005
Renal Solutions, Inc. Announces FDA 510(k) Clearance of the Allient® Sorbent Hemodialysis System for Chronic and Acute Hemodialysis


March 8, 2005
Renal Solutions, Inc. Completes $16.5 Million Series B Financing and Will Present at the SG Cowen Health Care Conference

January 4, 2005
SutureTek Closes its B Series Financing


December 27, 2004
Remon Medical Technologies Ltd. Completes Series C Financing, Raising $26 Million

December 6, 2004
Endocyte Secures Close to $23 Million in Series C-2 Round of Financing

October 5, 2004
Indiana Future Fund Invests in Triathlon Medical Ventures Fund

October 4, 2004
Triathlon Lands $96M in Venture Funding


BACK TO TOP

 
 
Copyright © 2004 - Triathlon Medical Ventures - All Rights Reserved Web Site Credits Legal Notices & Privacy Policy